CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Study to Evaluate the Activity of Commercially Available Molecularly Matched Targeted Therapies in Selected Tumor Types Based on Genomic Alterations

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02795156
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:39:26.261315+00:00
Published At: 2023-09-15T00:00:00+00:00
Record Updated At: 2023-12-05
Results Posted At: 2023-09-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Non-small Cell Lung Carcinoma", "Urothelial Carcinoma", "Gastrointestinal Carcinoma, Non-colon", "Upper Aerodigestive Tract Carcinoma"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2023-12-05"
protocolSection.identificationModule.nctId: "NCT02795156"
protocolSection.identificationModule.officialTitle: "Phase II Study to Evaluate the Activity of Commercially Available Molecularly Matched Targeted Therapies in Selected Tumor Types Based on Genomic Alterations"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2023-09-15"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.